INSPIREMD INC (NSPR) Stock Fundamental Analysis

NASDAQ:NSPR • US45779A8466

1.75 USD
+0.05 (+2.94%)
Last: Feb 13, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NSPR. NSPR was compared to 185 industry peers in the Health Care Equipment & Supplies industry. NSPR has a great financial health rating, but its profitability evaluates not so good. NSPR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • NSPR had negative earnings in the past year.
  • NSPR had a negative operating cash flow in the past year.
  • NSPR had negative earnings in each of the past 5 years.
  • In the past 5 years NSPR always reported negative operating cash flow.
NSPR Yearly Net Income VS EBIT VS OCF VS FCFNSPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • The Return On Assets of NSPR (-58.87%) is worse than 69.73% of its industry peers.
  • The Return On Equity of NSPR (-72.05%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -58.87%
ROE -72.05%
ROIC N/A
ROA(3y)-61.73%
ROA(5y)-56.41%
ROE(3y)-81.81%
ROE(5y)-75.32%
ROIC(3y)N/A
ROIC(5y)N/A
NSPR Yearly ROA, ROE, ROICNSPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

  • The Gross Margin of NSPR (24.91%) is worse than 78.92% of its industry peers.
  • In the last couple of years the Gross Margin of NSPR has remained more or less at the same level.
  • NSPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5Y1.01%
NSPR Yearly Profit, Operating, Gross MarginsNSPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • NSPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NSPR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NSPR has more shares outstanding
  • NSPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NSPR Yearly Shares OutstandingNSPR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NSPR Yearly Total Debt VS Total AssetsNSPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • NSPR has an Altman-Z score of -3.05. This is a bad value and indicates that NSPR is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -3.05, NSPR is not doing good in the industry: 63.24% of the companies in the same industry are doing better.
  • NSPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.05
ROIC/WACCN/A
WACC9.98%
NSPR Yearly LT Debt VS Equity VS FCFNSPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • A Current Ratio of 6.51 indicates that NSPR has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 6.51, NSPR belongs to the best of the industry, outperforming 83.78% of the companies in the same industry.
  • A Quick Ratio of 6.17 indicates that NSPR has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 6.17, NSPR belongs to the top of the industry, outperforming 87.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.51
Quick Ratio 6.17
NSPR Yearly Current Assets VS Current LiabilitesNSPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • NSPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.00%.
  • NSPR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.04%.
  • The Revenue has been growing by 13.51% on average over the past years. This is quite good.
EPS 1Y (TTM)-12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.25%
Revenue 1Y (TTM)14.04%
Revenue growth 3Y15.92%
Revenue growth 5Y13.51%
Sales Q2Q%39.39%

3.2 Future

  • NSPR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.56% yearly.
  • The Revenue is expected to grow by 76.78% on average over the next years. This is a very strong growth
EPS Next Y-10.5%
EPS Next 2Y-2.6%
EPS Next 3Y5.56%
EPS Next 5YN/A
Revenue Next Year22.32%
Revenue Next 2Y46.5%
Revenue Next 3Y76.78%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NSPR Yearly Revenue VS EstimatesNSPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
NSPR Yearly EPS VS EstimatesNSPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 -500K -1M -1.5M

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NSPR. In the last year negative earnings were reported.
  • Also next year NSPR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NSPR Price Earnings VS Forward Price EarningsNSPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NSPR Per share dataNSPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.6%
EPS Next 3Y5.56%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for NSPR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INSPIREMD INC

NASDAQ:NSPR (2/13/2026, 8:00:01 PM)

1.75

+0.05 (+2.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04
Earnings (Next)03-10
Inst Owners48.61%
Inst Owner Change1.4%
Ins Owners13.41%
Ins Owner Change18.3%
Market Cap74.15M
Revenue(TTM)7.78M
Net Income(TTM)-46.20M
Analysts82.5
Price Target4.08 (133.14%)
Short Float %0.09%
Short Ratio0.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.25%
Min EPS beat(2)1.96%
Max EPS beat(2)14.53%
EPS beat(4)3
Avg EPS beat(4)3.28%
Min EPS beat(4)-7.84%
Max EPS beat(4)14.53%
EPS beat(8)5
Avg EPS beat(8)0.43%
EPS beat(12)9
Avg EPS beat(12)6.98%
EPS beat(16)13
Avg EPS beat(16)11.88%
Revenue beat(2)2
Avg Revenue beat(2)27.63%
Min Revenue beat(2)14.71%
Max Revenue beat(2)40.56%
Revenue beat(4)4
Avg Revenue beat(4)15.96%
Min Revenue beat(4)3.38%
Max Revenue beat(4)40.56%
Revenue beat(8)7
Avg Revenue beat(8)9.62%
Revenue beat(12)11
Avg Revenue beat(12)8.9%
Revenue beat(16)14
Avg Revenue beat(16)7.41%
PT rev (1m)0%
PT rev (3m)-11.11%
EPS NQ rev (1m)3.34%
EPS NQ rev (3m)3.34%
EPS NY rev (1m)0%
EPS NY rev (3m)1.74%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)14.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.53
P/FCF N/A
P/OCF N/A
P/B 1.16
P/tB 1.16
EV/EBITDA N/A
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.77
OCFYN/A
SpS0.18
BVpS1.51
TBVpS1.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -58.87%
ROE -72.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.91%
FCFM N/A
ROA(3y)-61.73%
ROA(5y)-56.41%
ROE(3y)-81.81%
ROE(5y)-75.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5Y1.01%
F-Score4
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 390.57%
Cap/Sales 20.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.51
Quick Ratio 6.17
Altman-Z -3.05
F-Score4
WACC9.98%
ROIC/WACCN/A
Cap/Depr(3y)304.1%
Cap/Depr(5y)236.96%
Cap/Sales(3y)11.74%
Cap/Sales(5y)9.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.25%
EPS Next Y-10.5%
EPS Next 2Y-2.6%
EPS Next 3Y5.56%
EPS Next 5YN/A
Revenue 1Y (TTM)14.04%
Revenue growth 3Y15.92%
Revenue growth 5Y13.51%
Sales Q2Q%39.39%
Revenue Next Year22.32%
Revenue Next 2Y46.5%
Revenue Next 3Y76.78%
Revenue Next 5YN/A
EBIT growth 1Y-56.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-29.81%
EBIT Next 3Y-16.71%
EBIT Next 5YN/A
FCF growth 1Y-119.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.87%
OCF growth 3YN/A
OCF growth 5YN/A

INSPIREMD INC / NSPR FAQ

What is the ChartMill fundamental rating of INSPIREMD INC (NSPR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NSPR.


What is the valuation status for NSPR stock?

ChartMill assigns a valuation rating of 0 / 10 to INSPIREMD INC (NSPR). This can be considered as Overvalued.


Can you provide the profitability details for INSPIREMD INC?

INSPIREMD INC (NSPR) has a profitability rating of 1 / 10.


What is the expected EPS growth for INSPIREMD INC (NSPR) stock?

The Earnings per Share (EPS) of INSPIREMD INC (NSPR) is expected to decline by -10.5% in the next year.